Runliu Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Immunology top 10%
- interferon and immune responses
Papers in
-
- RNA modifications and cancer 6
- Inflammasome and immune disorders 5
- Protein Degradation and Inhibitors 3
- Cancer-related gene regulation 3
-
- Immune Response and Inflammation 4
- Immune cells in cancer 3
- Co-authors
- Rui Kang (18 shared papers)Daolin Tang (18 shared papers)Nian Wang (1 shared paper)Nian Wang (6 shared papers)Changwei Lin (10 shared papers)Guido Kroemer (4 shared papers)Herbert J. Zeh (6 shared papers)Xin Chen (2 shared papers)
- Journals
- Cell Death and Disease (3 papers)Science Advances (2 papers)Frontiers in Immunology (2 papers)Oncotarget (2 papers)Autophagy (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Runliu Wu
31 papers receiving 1.8k citations
Runliu Wu's Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 493
- Immunology 360
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 444
- Oncology 194
Countries citing papers authored by Runliu Wu
This map shows the geographic impact of Runliu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runliu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runliu Wu more than expected).
Fields of papers citing papers by Runliu Wu
This network shows the impact of papers produced by Runliu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runliu Wu. The network helps show where Runliu Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Runliu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The BET family in immunity and disease Hit paper breakdown → | 2021 | 212 |
| 2 | 2019 | 204 | |
| 3 | Tumor heterogeneity in autophagy-dependent ferroptosis Hit paper breakdown → | 2021 | 200 |
| 4 | Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer Hit paper breakdown → | 2023 | 192 |
| 5 | 2020 | 167 | |
| 6 | 2020 | 134 | |
| 7 | 2022 | 107 | |
| 8 | 2020 | 94 | |
| 9 | 2021 | 69 | |
| 10 | 2022 | 52 | |
| 11 | 2020 | 51 | |
| 12 | 2018 | 38 | |
| 13 | 2022 | 37 | |
| 14 | 2022 | 30 | |
| 15 | 2019 | 25 | |
| 16 | 2011 | 23 | |
| 17 | 2020 | 21 | |
| 18 | 2022 | 20 | |
| 19 | 2017 | 20 | |
| 20 | 2023 | 17 |
About Runliu Wu
Runliu Wu is a scholar working on Molecular Biology, Immunology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 31 papers that have together received 1.8k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Ferroptosis and cancer prognosis (5 papers), Inflammasome and immune disorders (5 papers), Cancer-related molecular mechanisms research (5 papers), Immune Response and Inflammation (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer-related gene regulation (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Cancer Research (493 citations), Immunology (360 citations), Molecular Biology (1.1k citations), Pulmonary and Respiratory Medicine (444 citations) and Oncology (194 citations). Runliu Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Rui Kang, Daolin Tang, Nian Wang, Nian Wang, Changwei Lin, Guido Kroemer, Herbert J. Zeh, Xin Chen, Lihua Huang and Daojiang Li. Their work appears in journals such as Cell Death and Disease, Science Advances, Frontiers in Immunology, Oncotarget and Autophagy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.